SavedAdd your journal

Journals / Marmara Medical Journal / 2026 / Volume: 29 Issue: 2 Special Issue

Histopathologic diagnosis of chronic viral hepatitis

Çiğdem Ataizi Çelikel
Pages
—
Publication Date
2016-08-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Continuednecroinflammatory activity at the limiting plate destroyingperiportal parenchyma initiates fibrogenesis leading to cirrhosis.Fibrosis can be reversible with fragmentation of scar tissue,resolving vascular derangements and parenchymal regeneration.Grading is a measure of the intensity of necroinflammatory activityand staging is a measure of fibrosis and architectural alteration.Besides staging, Laennec scoring system, subdividing cirrhosisthat is based on histologic parameters of fibrous septa width andnumber, has been advised to be used in reporting chronic viralhepatitis.Keywords: Viral hepatitis, Grading, Staging, Biopsy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Morphological evaluation of the liver continues to play a centralrole for the diagnosis, grading and staging of chronic viral hepatitis.The defining morphology is necroinflammation, that is hepatocyteinjury and inflammation.
📊
Key Findings & Data:Hepatocyte injury is usually irreversible,and presents as apoptosis and/or necrosis.
💡
Conclusion & Impact:Continuednecroinflammatory activity at the limiting plate destroyingperiportal parenchyma initiates fibrogenesis leading to cirrhosis.Fibrosis can be reversible with fragmentation of scar tissue,resolving vascular derangements and parenchymal regeneration.Grading is a measure of the intensity of necroinflammatory activityand staging is a measure of fibrosis and architectural alteration.Besides staging, Laennec scoring system, subdividing cirrhosisthat is based on histologic parameters of fibrous septa width andnumber, has been advised to be used in reporting chronic viralhepatitis.Keywords: Viral hepatitis, Grading, Staging, Biopsy
🔬Design:Article
📍Scope:Comprehensive Sample
⚙️Variables:Viral hepatit · Derecelendirme · Evreleme

Abstract

Morphological evaluation of the liver continues to play a centralrole for the diagnosis, grading and staging of chronic viral hepatitis.The defining morphology is necroinflammation, that is hepatocyteinjury and inflammation. Hepatocyte injury is usually irreversible,and presents as apoptosis and/or necrosis. Mononuclear cellinfiltration of the portal tracts, that is usually accompanied byperiportal (interface) and lobular inflammation is typical. Continuednecroinflammatory activity at the limiting plate destroyingperiportal parenchyma initiates fibrogenesis leading to cirrhosis.Fibrosis can be reversible with fragmentation of scar tissue,resolving vascular derangements and parenchymal regeneration.Grading is a measure of the intensity of necroinflammatory activityand staging is a measure of fibrosis and architectural alteration.Besides staging, Laennec scoring system, subdividing cirrhosisthat is based on histologic parameters of fibrous septa width andnumber, has been advised to be used in reporting chronic viralhepatitis.Keywords: Viral hepatitis, Grading, Staging, Biopsy

Özet

Morphological evaluation of the liver continues to play a centralrole for the diagnosis, grading and staging of chronic viral hepatitis.The defining morphology is necroinflammation, that is hepatocyteinjury and inflammation. Hepatocyte injury is usually irreversible,and presents as apoptosis and/or necrosis. Mononuclear cellinfiltration of the portal tracts, that is usually accompanied byperiportal (interface) and lobular inflammation is typical. Continuednecroinflammatory activity at the limiting plate destroyingperiportal parenchyma initiates fibrogenesis leading to cirrhosis.Fibrosis can be reversible with fragmentation of scar tissue,resolving vascular derangements and parenchymal regeneration.Grading is a measure of the intensity of necroinflammatory activityand staging is a measure of fibrosis and architectural alteration.Besides staging, Laennec scoring system, subdividing cirrhosisthat is based on histologic parameters of fibrous septa width andnumber, has been advised to be used in reporting chronic viralhepatitis.Keywords: Viral hepatitis, Grading, Staging, Biopsy

🔖

Cite This Article

Çelikel, Ç. A. (2016). Histopathologic diagnosis of chronic viral hepatitis. Marmara Medical Journal, Volume: 29 Issue: 2 Special Issue. https://doi.org/10.5472/MMJsi.2901.05

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (134)

  1. Scheuer PJ, Lefkowitch JH. Chronic hepatitis. In: Scheuer
  2. PJ, Lefkowitch JH, eds. Liver Biopsy Interpretation, 7th ed.
  3. Elsevier Saunders, 2005: 145-170.
  4. Theise ND, Bodenheimer HC, Ferrell LD. Acute and chronic
  5. viral hepatitis. In: Burt AD, Portmann BC, Ferrell L, eds.
  6. MacSween’s Pathology of the Liver, 6th ed. Edinburg
  7. Churchill-Livingstone-Elsevier, 2012:361-402.
  8. Hytiroglou P. Hepatitis B and C. In: Saxena R, ed. Practical
  9. Hepatic Pathology, 1th ed. Elsevier Saunders, 2011: 215-234.
  10. Yerian LM, Lamps LW. Acute and chronic infectious
  11. hepatitis. In: Odze DR, Goldblum JR, eds. Surgical Pathology
  12. of the GI Tract, Liver, Biliary Tract, and Pancreas, 3rd ed.
  13. Philedelphia: Elsevier Saunders, 2015:1228-1261.
  14. Guido M, Mangia A, Faa G. Chronic viral hepatitis: The
  15. histology report. Dig Liver Dis 2011;43:S331-S343.
  16. De Groote J, Desmet VJ, Gedigk P, et al. A classification of
  17. chronic hepatitis. Lancet 1968;2:262-8.
  18. Ludwig J, McFarlane IG, Rakela J and the International
  19. Working Party. Terminology of chronic hepatitis. Am J
  20. Gastroenterol 1995;90:181-9.
  21. Crawford JM, Burt AD. Anatomy, pathophysiology and basic
  22. mechanisms of disease. In: Burt AD, Portmann BC, Ferrell
  23. L, eds. MacSween’s Pathology of the Liver, 6th ed. Edinburg
  24. Churchill-Livingstone-Elsevier, 2012: 1-77.
  25. Theise ND. Liver biopsy assessment in chronic viral hepatitis
  26. a personal, practical approach. Modern Pathol 2007;20:S3-
  27. Schattenberg JM, Galle PR, Schuchmann M. Apoptosis in
  28. liver disease. Liver Int 2006;26:904-11.
  29. Hano H, Takasaki S, Endo Y, Harada T, Komine K, Koike
  30. Y. Histologic reassessment of the role of bridging fibrosis
  31. in the angioarchitectural features associated with lobular
  32. distortion of the liver in chronic viral hepatitis. Hepatol Res
  33. E70-8.
  34. Friedman SL. Mechanisms of hepatic fibrogenesis.
  35. Gastroenterol 2008;134:1655-69.
  36. Iwaisako K, Brenner DA, Kisseleva T. What’s new in liver
  37. fibrosis? The origin of myofibroblasts in liver fibrosis. J
  38. Gastroenterol Hepatol 2012;27(suppl 2):65-68.
  39. Wanless IR, Huang WY. Vascular disorders. In: Burt AD
  40. Portmann BC, Ferrell L, eds. MacSween’s Pathology of
  41. the Liver, 6th ed. Edinburg: Churchill-Livingstone-Elsevier
  42. Elpek GÖ. Angiogenesis and liver fibrosis. World J Hepatol
  43. Chen W, Rock JB, Yearsley MM, Ferrell LD, Frankel WL.
  44. Different collagen types show distinct rates of increase from
  45. early to late stages of hepatitis C-related liver fibrosis. Human
  46. Pathol 2014;45:160-5.
  47. Garcia-Tsao G, Iredale J, Pinzani. Now there are many (stages)
  48. where before there was one: in search of a pathophysiological
  49. classification of cirrhosis. Hepatology 2010;51:1445-9.
  50. Wanless IR, Nakashima E, Sherman M. Regression of human
  51. cirrhosis. Arch Pathol Lab Med 2000;124:1599-1607.
  52. Friedman SL. Fibrogenic cell reversion underlies fibrosis
  53. regression in liver. Proc Natl Acad Sci 2012;109:9230-1.
  54. Mani H, Kleiner DE. Liver biopsy findings in chronic
  55. hepatitis B. Hepatology 2009;49:S61-S71.
  56. Biazar T, Yahyapour Y, Roushan H, et al. Relationship
  57. between hepatitis B DNA viral load in the liver and its
  58. histology in patients with chronic hepatitis B. Caspian J
  59. Intern Med 2005;6:209-12.
  60. Tachtatzis PM, Marshall A, Arvinthan A, et al. Chronic
  61. hepatitis B virus infection: the relation between hepatitis
  62. B antigen expression, telomere length, senescence
  63. inflammation and fibrosis. PLoS One 2015;10:e0127511.
  64. Fiel MI. Pathology of chronic hepatitis B and chronic hepatitis
  65. C. Clin Liver Dis 2019;14:555.
  66. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ.
  67. Classification of chronic hepatitis: diagnosis, grading and
  68. staging. Hepatology 1994;19:1513-20.
  69. Knodell RG, Ishak KG, Black WC, et al. Formulation and
  70. application of a numerical scoring system for assessing
  71. histological activity in asymptomatic chronic active hepatitis.
  72. Hepatology 1981;1:431-5.
  73. Hübscher SG. Histological grading and staging in chronic
  74. hepatitis: clinical applications and problems. J Hepatol
  75. Ishak K, Baptista A, Bianchi L, et al. Histological grading
  76. and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
  77. Scheuer PJ. Classification of chronic viral hepatitis: a need
  78. for reassessment. J Hepatol 1991;13:372-4.
  79. Batts KP, Ludwig J. Chronic hepatitis: an update on
  80. terminology and reporting. Am J Surg Pathol 1995;19:1409-
  81. Bedossa P, Poynard T and the French METAVIR Cooperative
  82. Study Group. An algorithm for grading activity in chronic
  83. hepatitis C. Hepatology 1996;24:289-93.
  84. Goldin RD, Goldin JG, Burt AD, Dhillon PA, Wyatt J
  85. Patel N. Intra-observer and inter-observer variation in the
  86. histopathological assessment of chronic viral hepatitis. J
  87. Hepatol 1996;25:649-54.
  88. Rousselet MC, Michalak S, Dupre F, et al. Sources of
  89. variability in histological scoring of chronic viral hepatitis.
  90. Hepatology 2005;41:41:257.
  91. Paterson AL, Allison ME, Brais R, Davies SE. Any value in a
  92. specialist review of liver biopsies? Conclusions of a four-year
  93. review. Histopathology 2016 Jan 30. [Epub ahead of print]
  94. Kutami R, Girgrah N, Wanless IR, et al. The Laennec
  95. grading system for assessment of hepatic fibrosis: validation
  96. by correlation with wedged hepatic vein pressure and clinical
  97. features. Hepatology 2000;32:407A.
  98. Hytiroglu P, Snover DC, Alves V, et all. Beyond “Cirrhosis”
  99. A proposal from international liver pathology subgroup. Am
  100. J Clin Pathol 2012;137:5-9.
  101. Kim SU, Oh HJ, Wanless IR, Lee S, Han H, Park YN. The
  102. Laennec staging system for histological sub-classification of
  103. cirrhosis is useful for stratification of prognosis in patients
  104. with liver cirrhosis. J Hepatol 2012;57:556-63.
  105. Kim SU, Cho MY, Baik SK, et al. Histological subclassification
  106. of cirrhosis using the Laennec fibrosing scoring
  107. system correlates with clinical stage and grade of portal
  108. hypertension. J Hepatol 2011;55:1004-9.
  109. Narciso-Schiavon JL, Freire FC, Suarez MM, et al.
  110. Antinuclear antibody positivity in patients with chronic
  111. hepatitis C; clinically relevant or an epiphenomenon? Eur J
  112. Gastroenterol Hepatol 2009;21:440-6.
  113. Li BA, Liu J, Hou J, et al. Autoantibodies in Chinese patients
  114. with chronic hepatitis B: prevalence and clinical associations.
  115. World J Gastroenterol 2015;21:283-91.
  116. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith
  117. AD. Liver biopsy. Hepatology 2009;49:1017-43.
  118. Cholongitas E, Senzolo M, Standish R, et al. A systematic
  119. review of the quality of liver biopsy specimens. Am J Clin
  120. Pathol 2006;125:710-21.
  121. Colloredo G, Guidon M, Sonzogni A, Leandro G. Impact of
  122. liver biopsy size on histological evaluation of chronic viral
  123. hepatitis: the smaller the sample, the milder the disease. J
  124. Hepatol 2003;39:239-44.
  125. Schiano TD, Azeem S, Bodian CA, et al. Importance
  126. of specimen size in accurate needle biopsy evaluation of
  127. patients with chronic hepatitis C. Clin Gastroenterol Hepatol
  128. Bedossa P, Dargere D, Paradis V. Sampling variability of
  129. liver fibrosis in chronic hepatitis C. Hepatol 2003;38:1449.
  130. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Eng J Med
  131. Skripenova S, Trainer T, Krawitt E, Blaszyk H. Variability
  132. of grade and stage in simultaneous paired liver biopsies in
  133. patients with hepatitis C. J Clin Pathol 2007;60:321-4.
  134. Hepatol 2003;39:239-44.